Skip to main content

Advertisement

Table 1 Dietary intake, body weight and various organ weights

From: Anti-diabetic effect of sorghum extract on hepatic gluconeogenesis of streptozotocin-induced diabetic rats

  NC DM DM-SE 0.4 DM-SE 0.6 DM-G
Dietary intake (g/day) 22.10±0.23a 25.94±1.30b 26.65±1.60b 28.41±1.26b 27.11±1.27b
Initial body weight (g/day) 246.20±6.76a 208.60±7.79b 213.20±7.36b 206.60±9.27b 207.80±14.15b
Final body weight (g/day) 491.40±9.01a 375.40±43.17b 347.60±35.94b 385.40±30.44b 323.40±38.45b
Liver (mg/g body weight) 11.52±0.57a 11.40±0.66b 12.27±0.63b 12.04±0.30b 10.83±0.69b
kidney (mg/g body weight) 2.73±0.10a 2.91±0.07b 2.65±0.08b 2.72±0.06b 2.83±0.11b
Retroperitoneal fat (g) 12.11±1.07a 8.52±0.62b 8.32±1.60b 8.99±0.56b 6.78±0.34b
Epididymal fat (g) 11.82±0.81a 8.97±0.27b 6.73±1.44b 8.68±0.35b 6.40±1.27b
Perirenal fat (g) 0.99±0.21 0.93±0.15 0.94±0.15 0.75±0.15 0.84±016
  1. Values are expressed as the mean ± SEM (n = 5); NC, normal control rats administrated saline; DM, rats with diabetes mellitus administrated saline; DM-SE 0.4, rats with diabetes mellitus administrated 0.4 g/kg body weight of sorghum extract; DM-SE 0.6, rats with diabetes mellitus administrated 0.6 g/kg body weight of sorghum extract; DM-G, rats with diabetes mellitus administrated 0.7 mg/kg body weight of glibenclamide. The values in the rows with different letters are significantly different at p < 0.05 using ANOVA with Duncan’s multiple range test.